Loading company…
Transcenta Holding Ltd. is a Suzhou-based biopharmaceutical company that researches, develops and manufactures biologics.
Established in 2019 and based in Suzhou, China, Transcenta was formed by merging Hangzhou Just Biotherapeutics and MabSpace Biosciences, with product development and production in Hangzhou and clinical centers in Shanghai, Beijing and Boston, USA. The company develops nine new drug molecules across oncology, orthopedics and kidney disease, and has partnered with Libang Pharmaceutical to co-develop TST004 in China. It has raised more than USD 342 million and is listed at the Late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in